Literature DB >> 26826783

Beyond Tsetse--Implications for Research and Control of Human African Trypanosomiasis Epidemics.

Susan C Welburn1, David H Molyneux2, Ian Maudlin3.   

Abstract

Epidemics of both forms of human African trypanosomiasis (HAT) are confined to spatially stable foci in Sub-Saharan Africa while tsetse distribution is widespread. Infection rates of Trypanosoma brucei gambiense in tsetse are extremely low and cannot account for the catastrophic epidemics of Gambian HAT (gHAT) seen over the past century. Here we examine the origins of gHAT epidemics and evidence implicating human genetics in HAT epidemiology. We discuss the role of stress causing breakdown of heritable tolerance in silent disease carriers generating gHAT outbreaks and see how peculiarities in the epidemiologies of gHAT and Rhodesian HAT (rHAT) impact on strategies for disease control.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  HAT; epidemics; epigenetics; famine; sleeping sickness; tsetse

Mesh:

Year:  2016        PMID: 26826783     DOI: 10.1016/j.pt.2015.11.008

Source DB:  PubMed          Journal:  Trends Parasitol        ISSN: 1471-4922


  27 in total

1.  Steric constraints control processing of glycosylphosphatidylinositol anchors in Trypanosoma brucei.

Authors:  Carolina M Koeller; Calvin Tiengwe; Kevin J Schwartz; James D Bangs
Journal:  J Biol Chem       Date:  2020-01-13       Impact factor: 5.157

Review 2.  Dynamic protein S-palmitoylation mediates parasite life cycle progression and diverse mechanisms of virulence.

Authors:  Robert W B Brown; Aabha I Sharma; David M Engman
Journal:  Crit Rev Biochem Mol Biol       Date:  2017-02-20       Impact factor: 8.250

3.  Genetic Differentiation of Glossina pallidipes Tsetse Flies in Southern Kenya.

Authors:  Winnie A Okeyo; Norah P Saarman; Rosemary Bateta; Kirstin Dion; Michael Mengual; Paul O Mireji; Collins Ouma; Sylvance Okoth; Grace Murilla; Serap Aksoy; Adalgisa Caccone
Journal:  Am J Trop Med Hyg       Date:  2018-10       Impact factor: 2.345

Review 4.  Anti-trypanosomatid drug discovery: an ongoing challenge and a continuing need.

Authors:  Mark C Field; David Horn; Alan H Fairlamb; Michael A J Ferguson; David W Gray; Kevin D Read; Manu De Rycker; Leah S Torrie; Paul G Wyatt; Susan Wyllie; Ian H Gilbert
Journal:  Nat Rev Microbiol       Date:  2017-02-27       Impact factor: 60.633

Review 5.  New Approaches to Overcome Transport Related Drug Resistance in Trypanosomatid Parasites.

Authors:  Jose A Garcia-Salcedo; Juan D Unciti-Broceta; Javier Valverde-Pozo; Miguel Soriano
Journal:  Front Pharmacol       Date:  2016-09-28       Impact factor: 5.810

6.  Novel Financing Model for Neglected Tropical Diseases: Development Impact Bonds Applied to Sleeping Sickness and Rabies Control.

Authors:  Susan Christina Welburn; Kevin Louis Bardosh; Paul Gerard Coleman
Journal:  PLoS Negl Trop Dis       Date:  2016-11-17

7.  Trypanosoma brucei Invasion and T-Cell Infiltration of the Brain Parenchyma in Experimental Sleeping Sickness: Timing and Correlation with Functional Changes.

Authors:  Claudia Laperchia; Maria Palomba; Paul F Seke Etet; Jean Rodgers; Barbara Bradley; Paul Montague; Gigliola Grassi-Zucconi; Peter G E Kennedy; Marina Bentivoglio
Journal:  PLoS Negl Trop Dis       Date:  2016-12-21

8.  A Multi-Host Agent-Based Model for a Zoonotic, Vector-Borne Disease. A Case Study on Trypanosomiasis in Eastern Province, Zambia.

Authors:  Simon Alderton; Ewan T Macleod; Neil E Anderson; Kathrin Schaten; Joanna Kuleszo; Martin Simuunza; Susan C Welburn; Peter M Atkinson
Journal:  PLoS Negl Trop Dis       Date:  2016-12-27

9.  Forecasting Human African Trypanosomiasis Prevalences from Population Screening Data Using Continuous Time Models.

Authors:  Harwin de Vries; Albert P M Wagelmans; Epco Hasker; Crispin Lumbala; Pascal Lutumba; Sake J de Vlas; Joris van de Klundert
Journal:  PLoS Comput Biol       Date:  2016-09-22       Impact factor: 4.475

10.  Including refugees in disease elimination: challenges observed from a sleeping sickness programme in Uganda.

Authors:  Jennifer J Palmer; Okello Robert; Freddie Kansiime
Journal:  Confl Health       Date:  2017-12-01       Impact factor: 2.723

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.